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Abstract
Substance dependence or addiction is a complex environmental and genetic disorder that results in serious health and
socio-economic consequences. Multiple substance dependence categories together, rather than any one individual
addiction outcome, may explain the genetic variability of such disorder. In our study, we defined a composite substance
dependence phenotype derived from six individual diagnoses: addiction to nicotine, alcohol, marijuana, cocaine, opiates or
other drugs as a whole. Using data from several genomewide case-control studies, we identified a strong (Odds ratio =1.77)
and significant (p-value=7E-8) association signal with a novel gene, PBX/knotted 1 homeobox 2 (PKNOX2), on chromosome
11 with the composite phenotype in European-origin women. The association signal is not as significant when individual
outcomes for addiction are considered, or in males or African-origin population. Our findings underscore the importance of
considering multiple addiction types and the importance of considering population and gender stratification when
analyzing data with heterogeneous population.
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Introduction
Substance dependence or addiction is one of the most sought-
after phenomena in many populations because of its serious health
and socio-economic consequences. In 2008, the Centers for
Disease Control estimated that 443,000 deaths were caused by
cigarette smoking and exposure to secondhand smoke [1]. In
addition, alcohol misuse has been linked to attempted and
successful suicide, particularly among adolescents [2]. There is
strong evidence that vulnerability to substance dependence to
drugs, alcohol, or smoking is a complex trait with both genetic and
environmental components [3,4,5]. Therefore, a better under-
standing of the genetics behind vulnerability to addictions could
tremendously improve overall health and quality of life in general.
A useful start in this direction is given by Kreek et al. [6] In the
literature, candidate genes for addiction to individual substances
(alcohol, nicotine and other substances) have been identified. For
example, well studied genes for alcohol dependence, such as
GABRA2, CHRM2 and ADH4, have been replicated in many
samples [7,8,9,10], while several newer candidate genes
(GABRG3, TAS2R16, SNCA, OPRK1 and PDYN) remain to
be confirmed [11]. Multiple variants at the aldehyde dehydroge-
nase (ALDH) and alcohol dehydrogenase (ADH) loci have also
been well documented as genes of major genetic effect especially in
East-Asian populations [12,13,14,15]. A gene cluster of nicotinic
acetylcholine receptors (CHRNA5, CHRNA3, and CHRNB4)
and Neurexin1, also show allelic differences in heavy vs. light
smokers in multiple studies [16,17,18,19]. Li [20] reported thirteen
regions on chromosomes 3–7, 9–11, 17, 20, and 22, to be
significantly associated with nicotine dependence in at least two
independent samples, although a significant number of reported
genomic regions did not reach the level of ‘‘suggestive’’ or
‘‘significant’’ linkage and failed to be replicated in other
independent studies.
In the past, much effort has been devoted to the emphasis on
individually different substance dependence outcomes. However,
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nicotine, alcohol, marijuana, cocaine, opiates and other drugs,
has not been thoroughly investigated in association studies. A
composite substance dependence phenotype may be the key to
finding a common genetic predisposition of substance dependence
as a whole. This common genetic predisposition may not be
apparent when individual addiction conditions are considered. In
the literature, Li and Burmeister [21] provide a good review of
comorbidity in the genetics of addiction. The availability of the
Gene Environment Association Studies Genes and Environment
Initiative Study of Addiction: Genetics and Environment (SAGE)
data provides an unprecedented opportunity to study the genetics
of a composite trait: namely, addiction to at least two of the six
substances under study (nicotine, alcohol, marijuana, cocaine,
opiates and other drugs).
In this report, we present a genomewide significant association
(a=0.05) of PKNOX2 gene on chromosome 11 with composite
substance dependence in European-origin women. We have
identified a cluster of markers in the region of PKNOX2 gene
that are strongly associated with a composite addiction phenotype
rather than with any single addiction type. Furthermore, we
investigate potential sex-specificity and racial differences in the
association. The nuclear transcription factor PKNOX2 has been
previously identified as one of the cis-regulated genes for alcohol
addiction in mice [22]. However, to our knowledge, PKNOX2 has
not been reported to be associated with any substance addiction
outcomes in human populations. Thus we present PKNOX2 as a
novel candidate gene for substance dependence in humans.
Methods
Study of Addiction: Genetics and Environment (SAGE)
Data
We obtained the genomewide single nucleotide polymorphisms
(SNP) data from the database of Genotype and Phenotype
(dbGaP). The data were from the Study of Addiction: Genetics
and Environment (SAGE) (Bierut et al. 2010). We included 4,121
subjects for whom the addiction to the six categories of substances
and genomewide SNP data (ILLUMINA Human 1M platform)
were available. SAGE is a case-control study of mostly unrelated
individuals aimed at identifying genetic associations for addiction.
Cases and controls were selected from three large, complementary
cohorts: Collaborative Study on the Genetics of Alcoholism
(COGA, initiated in 1989), Family Study of Cocaine Dependence
(FSCD, 2000–2006), and Collaborative Genetic Study of Nicotine
Dependence (COGEND, initiated in 2000). These three studies
have been previously described [8,23,24,25]. Lifetime dependence
on nicotine, alcohol, marijuana, cocaine, opiates or other
dependence on other drugs was diagnosed in accordance with
the Diagnostic and Statistical Manual of Mental Disorders, Fourth
Edition (DSM-IV). As stated above, we studied a composite
addiction phenotype according to whether a subject was addicted
to substances in at least two of the aforementioned categories.
Subject Characteristics and Study Design
To reduce the level of noise in genotypes and increase the
efficiency of analysis, we filtered SNPs by setting thresholds for
minor allele frequency (MAF) and call rate (i.e., MAF .5% and
call rate .90%). In addition, we excluded 60 duplicate genotype
samples and removed 9 subjects with ethnic backgrounds other
than African-origin (Black) or European-origin (White). Table 1
lists the descriptive statistics of the sample included in our study.
Almost all subjects were either Black (30.3%) or White (69.4%).
In our final analysis, a total of 3,627 unrelated subjects with
830,696 autosomal SNPs were included. The final subset
considered in the analysis consisted of 45.9% men and 54.1%
women with mean ages of 39.4 and 38.6 years old, respectively.
Because substance dependence is a complex disease with both
genetic and environmental components, we analyzed the male and
female subsets separately. In addition, we performed separate
analysis for Blacks and Whites in light of the possibility that
underlying genetic variants may be different in different ethnic
groups. Thus our study included four sub-samples: 1,393 White
women, 1,131 White men, 568 Black women and 535 Black men.
Overall a total of 1,513 subjects were defined as having two or
more substance addictions according to DSM-IV. Of these, there
were 316, 585, 237 and 375 subjects in the Black male, White
male, Black female and White female subsets, respectively. The
proportions of subjects diagnosed with lifetime dependence on
substances in each of the six categories – nicotine, alcohol,
marijuana, cocaine, opiates or other drugs – are presented in
Table 1. The top three most widely used substances among the six
were alcohol, nicotine and cocaine, in that order (Figure 1).
Statistical Analysis
We took precaution to investigate and control for potential
confounding by stratification and admixture due to disequilibrium
Table 1. Descriptive statistics of the sample stratified by sex and race.
Black Men White Men Black Women White Women Overall
n 535 1131 568 1393 3627
Age (SD) yr. 40.9 (8.2) 38.7 (10.3) 39.7 (6.7) 38.2 (9.1) 39.0 (9.1)
Height (SD) m 1.78 (0.08) 1.79 (0.07) 1.64 (0.08) 1.65 (0.07) 1.71 (0.10)
Weight (SD) kg 89.7 (18.3) 88.7 (16.8) 85.0 (21.9) 72.4 (18.8) 81.1 (20.1)
Alcohol (%) 62.1 62.3 39.4 31.1 46.7
Cocaine (%) 46.4 27.3 36.3 12.5 25.8
Marijuana (%) 25.4 25.2 13.7 8.7 17.1
Nicotine (%) 47.5 46.7 47.7 41.1 44.8
Opiates (%) 8.2 9.9 6.2 4.8 7.1
Other drugs (%) 11.4 18.0 6.5 9.4 11.9
No drug (%) 27.1 31.0 38.9 50.1 39.0
doi:10.1371/journal.pone.0016002.t001
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populations in our data. To avoid potential population stratifica-
tion, we first stratified our analysis by race and sex. Then we
performed formal population stratification analysis for each subset
using PLINK software (version 1.04) [27]. The results confirmed
that each subset comes from a homogenous population; thus no
further adjustment was needed to control for potential confound-
ing by stratification and admixture.
We used allelic Chi-square tests with 1 degree of freedom in our
analysis, stratified by race and sex. Haploview (version 4.0) [28]
was used to analyze the linkage disequilbrium in the PKNOX2
gene region and the association between the haplotypes and the
composite phenotype. We performed additional analyses by
examining and comparing the results of including and excluding
214 related subjects in the data. For mixtures of unrelated and
related subjects, we used PedGenie [29] to perform association
analyses. PedGenie first performs the allelic Chi-square tests
treating all individuals independently, then takes the pedigree
information into account to assess statistical significance through
permutation analysis.
Determination of Significance Threshold for GWAS
Using genotypes from the Wellcome Trust Case-Control
Consortium, Dudbridge and Gusnanto [30] studied the genome-
wide significance threshold for the UK Caucasian population.
They subsampled the genotypes at different densities and
estimated the threshold for 5% family-wise error using permuta-
tions. They then extrapolated to infinity density and estimated that
the genomewide significance threshold for this population is 7.2E-
8. We used this genomewide significance threshold (7.2E-8) for the
Caucasian population (white men and white women) in our
analysis.
Results
The top 8 significant SNPs are summarized in Table 2. They
cluster in PKNOX2 on chromosome 11 (11q24). None of the 8
SNPs violates the Hardy Weinberg equilibrium assumption
(minimum p-level =0.12). Among them, rs12284594 is the most
significant SNP (p-value=7.13E-08) observed in White women
with an odds ratio (OR) of 1.77, suggesting that those who have
the risk allele (G) for rs12284594 are at significantly increased risk
of being diagnosed with at least two of the six categories of
substance dependence. This p-value reaches the accepted genome-
wide significance level [30]. In addition, there are 7 other SNPs
with p-values less than 3.8E-06 in White women with similar ORs
(1.63 - 1.72). We further examined association of haplotypes with
the composite phenotype in this region, but they did not enhance
the strength of the associations; hence these results are not
reported here. Similarly, when related individuals were included in
the analysis, the strength of association was not enhanced, whether
the analysis was performed using PedGenie [29], or whether the
correlation among related individuals was ignored (data not
shown). Although we also observed that these 8 SNPs confer
increased risk in White men, Black men and Black women, they
fail to reach genomewide significance. Hence, detailed results are
not presented here for these groups.
We performed additional analyses to examine each substance
dependence outcome separately for the top 8 SNPs presented above.
T a b l e3s h o w st h ec o r r e s p o n d i n gp - v a l u e sf o rt h e8S N P sf o re a c h
substance dependence outcome. Alcohol dependence shows the
strongest association (p-value=1.97E-6 with rs12284594); however
none of these p-values attains the genomewide significance level of 0.05.
Discussion
We have found a novel, genomewide significant association of a
composite substance dependence phenotype with a SNP in the
PKNOX2 gene in White women. PKNOX2, PBX/knotted 1
homeobox 2, belongs to the three-amino-acid loop extension
(TALE) homeobox family. Homeodomain proteins are highly
conserved transcription regulators. Imoto et al. [31] identified
PKNOX2 as a novel TALE homeodomain-encoding gene,
located at 11q24 in humans and it functions as a nuclear
transcription factor indicated by its structure and sub-cellular
localization. Later, PKNOX2 was identified as one of the cis-
regulated genes for alcohol addiction in mice [22]. However,
Figure 1. Number of substance dependent subjects according
to DSM-IV for the top three addiction categories: alcohol (A),
nicotine (N) and cocaine (C). (i) is based on the overall sample and
(ii) is based on the White women subset.
doi:10.1371/journal.pone.0016002.g001
Table 2. Summary of the 8 most significant SNPs in PKNOX2
gene showing genomewide significant association with
substance dependence in White women.
SNP P-value OR
rs1426153 (G) 1.84E-06 1.66
rs11220015(A) 1.97E-06 1.65
rs11602925(G) 1.24E-06 1.67
rs750338(C) 4.22E-07 1.63
rs12273605(T) 3.83E-06 1.71
rs10893365(C) 2.27E-07 1.72
rs10893366(T) 6.87E-07 1.70
rs12284594(G) 7.13E-08 1.77
The high-risk allele is in the parenthesis.
doi:10.1371/journal.pone.0016002.t002
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substance dependence phenotype in humans to date.
The composite dichotomous substance dependence variable
reflects cases with two or more addictions where the top three
categories are alcohol, nicotine and cocaine (Figure 1). Among the
cases, 47% have been diagnosed with alcohol dependence in
combination with other substance dependence outcomes. Our
results, which show a strong association of this composite substance
dependence variable with PKNOX2 gene in a human sample,
support the experimental findings in mice by Mulligan et al [22].
Thus our findings make an important contribution in reporting
PKNOX2 as a novel candidate gene for substance dependence in
humans, particularly for White women in the SAGE sample.
Interestingly, among our most significant SNPs, we do not
observe those genes previously reported for alcoholism or nicotine.
Rather we find a new set of genes among the top SNPs. When
each substance dependence outcome was individually analyzed for
association with the 8 most significant SNPs, we found no
association that reached the genomewide significance. This
suggests that substance dependence or addiction as a whole has
different risk genes compared to any single addiction outcome. It
may also mean that there is more power in detecting common
genes acting upon co-morbid addiction outcomes as a whole.
For many complex diseases, different ethnic groups have vastly
different underlying genetics, and these differences may confound
association results when they are pooled together as one in the analysis.
Previously, racial differences in the prevalence of substance abuse have
been reported [32,33,34]. More recently, Luo et al. [24] have reported
that genetic differences between Black smokers and White smokers
influence the nature of their nicotine dependence. Their analysis
suggested that Black smokers become dependent at a lower threshold
(number cigarettes per day) than Whites. On the other side, in the
presence of subjects in different ethnic populations in the data, it is
crucial to investigate and control for potential confounding by
stratification and admixture due to disequilibrium between pairs of
unlinked loci [26]. Thus we investigated these two major ethnic groups
separately in our analysis. In addition, we stratified our analysis by
gender; based on the premise that gender may be a confounding factor
for the substance dependence outcome – men may be socially more
prone to environmental influences promoting substance use, and thus
more vulnerable to addiction, compared to women [35]. Our results
from the two ethnic groups do not corroborate each other, which
underscores the underlying genetic differences in White and Black
samples. In fact, strong association signals are observed only in the
White woman sample. With a heterogeneous population like SAGE,
one must be cautious in analyzing and interpreting the results.
The identification of PKNOX2 as a candidate gene for
substance use disorders underscores two important issues: (a) this
has not been possible in the past due to limited sample size; and (b)
we have considered a composite trait of six substance dependence
outcomes as a whole. The association becomes less significant if
individual substance addictions are considered. Thus, this result
highlights the importance of studying highly comorbid disorders or
those which might otherwise have a common pathway. However,
our study is limited to the information in the available data, and
we acknowledge the difficulty in operationalizing substance
dependence; whether our operationalization of addiction to two
or more substances, truly reflects the strength of the addiction
phenotype is open to question. Indeed, it may simply reflect the
extent of access to drugs. We also recognize that dependence on
one substance shows different characteristics from dependence on
another, and it is valuable and necessary to study them as
individual entities. However, our call for more attention to
comorbidity and the combinatorial study of these disorders should
be viewed as a valuable complementary effort.
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